In 1998 the definition of type 2 diabetes was revised, in particular the fasting plasma glucose (FPG) diagnostic level was lowered from 7.8 mmol/L to 7.0 mmol/L. The purpose of this study was to examine the effects of this change on patient demographics. Materials & Methods: We reviewed data from 1700 type 2 diabetes patients, who attended the St. Paul’s Hospital Diabetes Teaching and Train-ing Centre before (group 1) and after (group 2) the definition change. Demographical data from a baseline and follow-up were analyzed. The frequencies of patients in groups and cohorts <60 years of age and ≥60 years of age were calculated and HbA1c data was analyzed. Results: Compared to Group 1, Group 2 was younger, had a significantly lower mean HbA1c level (7.3% vs 8.1%, p<0.0001), blood pressure (127/78 vs 133/82 mmHg, p<0.05) and cholesterol (5.2 vs 5.5 mmol, p<0.05) and was more often treated with multiple medications (p<0.001). Pa-tients in Group 2 were significantly more likely to meet the target HbA1c level of 7.0% than pa-tients in Group 1 (p<0.0001). It was also found that at baseline, patients ≥60 years old in Group 2 had significantly lower HbA1c values than those <60 years old (p<0.001). Conclusion: Since the change in the definition of type 2 diabetes, a greater frequency of patients presented with lower mean HbA1c values and met target HbA1c levels. Patients ≥60 years old initially presented with lower HbA1c levels than those <60 years old.

"/> In 1998 the definition of type 2 diabetes was revised, in particular the fasting plasma glucose (FPG) diagnostic level was lowered from 7.8 mmol/L to 7.0 mmol/L. The purpose of this study was to examine the effects of this change on patient demographics. Materials & Methods: We reviewed data from 1700 type 2 diabetes patients, who attended the St. Paul’s Hospital Diabetes Teaching and Train-ing Centre before (group 1) and after (group 2) the definition change. Demographical data from a baseline and follow-up were analyzed. The frequencies of patients in groups and cohorts <60 years of age and ≥60 years of age were calculated and HbA1c data was analyzed. Results: Compared to Group 1, Group 2 was younger, had a significantly lower mean HbA1c level (7.3% vs 8.1%, p<0.0001), blood pressure (127/78 vs 133/82 mmHg, p<0.05) and cholesterol (5.2 vs 5.5 mmol, p<0.05) and was more often treated with multiple medications (p<0.001). Pa-tients in Group 2 were significantly more likely to meet the target HbA1c level of 7.0% than pa-tients in Group 1 (p<0.0001). It was also found that at baseline, patients ≥60 years old in Group 2 had significantly lower HbA1c values than those <60 years old (p<0.001). Conclusion: Since the change in the definition of type 2 diabetes, a greater frequency of patients presented with lower mean HbA1c values and met target HbA1c levels. Patients ≥60 years old initially presented with lower HbA1c levels than those <60 years old.

"/>

The Effect of the Change in the Definition of Type 2 Diabetes on Patient Demographics

AUTHORS

H D Tildesley 1 , * , J S Wise 2 , A B Mazanderani 2 , C A Aydin 2 , T S Fraser 2 , E Yu 2

1 Division of Endocrinology, St. Pauls Hospital and Department of Medicine,University of British Columbia, [email protected], British Colombia, Canada

2 Department of Medicine,University of British Columbia, British Colombia, Canada

How to Cite: Tildesley H, Wise J, Mazanderani A, Aydin C, Fraser T, et al. The Effect of the Change in the Definition of Type 2 Diabetes on Patient Demographics, Int J Endocrinol Metab. Online ahead of Print ; 7(2):51-55.

ARTICLE INFORMATION

International Journal of Endocrinology and Metabolism: 7 (2); 51-55
Article Type: Original Article
Received: January 1, 2008
Accepted: May 1, 2009
READ FULL TEXT

Abstract

In 1998 the definition of type 2 diabetes was revised, in particular the fasting plasma glucose (FPG) diagnostic level was lowered from 7.8 mmol/L to 7.0 mmol/L. The purpose of this study was to examine the effects of this change on patient demographics. Materials & Methods: We reviewed data from 1700 type 2 diabetes patients, who attended the St. Paul’s Hospital Diabetes Teaching and Train-ing Centre before (group 1) and after (group 2) the definition change. Demographical data from a baseline and follow-up were analyzed. The frequencies of patients in groups and cohorts <60 years of age and ≥60 years of age were calculated and HbA1c data was analyzed. Results: Compared to Group 1, Group 2 was younger, had a significantly lower mean HbA1c level (7.3% vs 8.1%, p<0.0001), blood pressure (127/78 vs 133/82 mmHg, p<0.05) and cholesterol (5.2 vs 5.5 mmol, p<0.05) and was more often treated with multiple medications (p<0.001). Pa-tients in Group 2 were significantly more likely to meet the target HbA1c level of 7.0% than pa-tients in Group 1 (p<0.0001). It was also found that at baseline, patients ≥60 years old in Group 2 had significantly lower HbA1c values than those <60 years old (p<0.001). Conclusion: Since the change in the definition of type 2 diabetes, a greater frequency of patients presented with lower mean HbA1c values and met target HbA1c levels. Patients ≥60 years old initially presented with lower HbA1c levels than those <60 years old.

Full Text

Full text is available in PDF

© 0, International Journal of Endocrinology and Metabolism. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
COMMENTS

LEAVE A COMMENT HERE: